C. C. Woodroofe et al. / Tetrahedron 61 (2005) 3097–3105
3103
130.1, 125.0, 124.0, 121.7, 117.5, 117.1, 80.4. IR:
3091 cmK1 (br, w), 1779 cmK1 (s), 1599 cmK1 (s),
1564 cmK1 (s), 1481 cmK1 (s), 1425–1384 cmK1 (br, s),
1318 cmK1 (m), 1251–1083 cmK1 (br, m), 954 cmK1 (s).
HRMS(M–ClCOH): Calcd 446.9497; Found 446.9503.
Calcd 503.0913; Found 503.0912. The dipivaloyl-protected
sulfonamide product 7 was also isolated from the organic
reaction extract by flash chromatography on silica eluted
with 94:6 CHCl3:MeOH; mp 184–186 8C. 1H NMR
(MeOH-d4): d 8.38 (m, 2H); 8.09 (dd, 1H, JZ8.1,
1.8 Hz); 7.61 (td, 1H, JZ7.8, 2.1 Hz); 7.25 (s, 1H); 7.21–
7.12 (m, 3H), 7.05 (d, 1H, JZ2.1 Hz); 6.84–6.77 (m, 3H);
6.70 (d, 2H, JZ8.4 Hz); 4.40 (s, 2H); 1.36 (s, 18H). 13C
NMR (DMSO-d6): d 176.1, 167.1, 156.5, 155.0, 152.7,
150.9, 148.8, 143.6, 136.8, 133.7, 129.4, 126.1, 125.2,
123.5, 122.6, 122.2, 118.7, 115.3, 110.5, 81.4, 48.0, 38.8,
26.7. HRMS (MCH): Calcd 671.2063; Found 671.2071.
4.2.10. 30, 60-Dichlorofluoran-6-sulfonamido-2-methyl-
pyridine (4). 30,60-Dichlorofluoran-6-sulfonyl chloride (4,
86 mg, 0.2 mmol) was dissolved in 15 mL of CH2Cl2 and
added dropwise to a stirred suspension of 2-aminomethyl-
pyridine (43 mg, 0.4 mmol) and NaHCO3 (84 mg, 1 mmol)
in CH2Cl2. After stirring overnight, the reaction suspension
was filtered and evaporated; the product was purified by
flash chromatography on silica gel (10 mm!17 cm) eluting
with 9:1 CHCl3:MeOH, and then recrystallized from
methanol to give 30 mg (30%) of an off-white powder;
4.2.13. 30,60-Dibromofluoran (8). 3-Bromophenol (1.73 g,
10 mmol) and phthalic anhydride (740 mg, 5 mmol) were
combined in 5 mL of methanesulfonic acid and heated in a
140 8C oil bath for 16 h. The reaction was poured into
120 mL of stirred ice water, stirred for 20 min, and then
filtered. The resulting damp gray solid was taken up in
CHCl3 and filtered through a short plug of silica gel,
evaporated, and recrystallized from CH2Cl2 and MeOH to
afford the desired product as 990 mg of off-white crystals
(43% yield); mp 277–280 8C. 1H NMR (CDCl3): d 8.05 (dd,
1H, JZ7.8, 1.5 Hz); 7.67 (p, 2H, JZ1.2 Hz); 7.50 (d, 2H,
JZ1.8 Hz); 7.20 (dd, 2H, JZ10.5, 2.1 Hz); 7.14 (d, 1H, JZ
7.8 Hz); 6.71 (d, 2H, JZ8.4 Hz). 13C NMR (CDCl3): d
169.4, 153.2, 151.5, 135.9, 130.7, 129.6, 127.9, 126.2,
125.9, 124.6, 124.1, 120.8, 118.3, 81.5. HRMS(MCH):
Calcd 456.9075; Found 456.9084.
1
mp 236–238 8C. H NMR (DMSO-d6): d 8.59 (t, 1H, JZ
5.7 Hz), 8.31 (d, 1H,, JZ4.8 Hz), 8.20 (d, 1H, JZ8.4 Hz),
8.08 (dd, 1H, JZ8.7, 0.6 Hz), 7.76 (s, 1H), 7.66 (td, 1H, JZ
7.8, 2.1 Hz), 7.61 (d, 2H, JZ1.8 Hz), 7.15–7.26 (m, 3H),
6.91 (d, 2H, JZ8.4 Hz), 4.12 (d, 2H, JZ6.0 Hz). 13C NMR
(DMSO-d6): d 168.2, 157.5, 153.6, 151.8, 149.8, 149.3,
137.9, 136.7, 131.1, 130.0, 129.3, 127.6, 126.1, 123.7,
123.2, 122.8, 118.2, 118.0, 81.9, 48.9. MS(M-H): Calcd
537.0; Found 537.1. X-ray quality crystals were obtained by
slow evaporation of a saturated acetonitrile solution of 4 at
RT over 2 days.
4.2.11. 30,60-Dipivaloylfluorescein-6-sulfonyl chloride
(5). 30,60-Dipivaloylfluorescein-6-sulfonate diisopropyl-
ethylammonium salt (708 mg, 1 mmol) was stirred in
10 mL of ethyl acetate (dried over MgSO4) in an ice bath.
Oxalyl chloride (1 mL of 2 M solution in CH2Cl2) was
added, followed by 200 mL of DMF. The ice bath was
removed, and the reaction was stirred for 16 h. The reaction
was then placed on ice and quenched with 10 mL of H2O.
The layers were separated, and the organic layer was
washed with 1!10 mL H2O and 1!10 mL brine, dried,
and evaporated to give a yellow solid residue; mp O160 8C
4.2.014. 30,60-Pyrrolidinorhodamine (9)—method A.
30,6 -Dibromofluoran (46 mg, 0.1 mmol) was combined
with ZnCl2 (68 mg, 0.5 mmol) and pyrrolidine (83 mL,
71 mg, 1 mmol) and heated in a 170 8C oil bath for 4 h. The
reaction was removed from heat, and allowed to cool. Water
and concentrated HCl were added; the suspension was
stirred, filtered, and the solid was washed twice with
dilute HCl to afford a purple solid (42 mg, 95% yield); mp
1
1
O220 8C (decomp.). H NMR (MeOH-d4): d 8.34 (d, 1H,
(decomp.). H NMR (CDCl3): d 8.68 (s, 1H); 8.31 (d, 1H,
JZ7.5 Hz); 7.81 (m, 2H); 7.41 (d, 1H, JZ8.7 Hz); 7.12 (d,
2H, JZ9.3 Hz); 6.90 (dd, 2H, JZ6.9, 1.8 Hz); 6.82 (d, 2H,
JZ2.1 Hz); 3.61 (m, 8H); 2.14 (s, 8H). 13C NMR (DMSO-
d6): d 169.0, 152.7, 152.3, 152.3, 149.2, 135.3, 129.8, 128.9,
128.5, 128.3, 126.7, 125.4, 124.5, 124.0, 108.8, 105.4, 97.4,
85.4, 47.4, 25.0. MS(MCH): Calcd 439.2; Found 439.4.
JZ6.8 Hz); 7.45 (d, 1H, JZ6.5 Hz); 7.18 (s, 2H); 6.84 (s,
2H); 1.37 (s, 18H). HRMS(MCH): Calcd 599.1143; Found
599.1114.
4.2.12. 6-Fluoresceinsulfonamido-2-methylpyridine (6).
The product from 5 was dissolved in 20 mL of CHCl3 and
stirred in an ice bath. 2-Aminomethylpyridine (300 mL) was
added and the reaction was stirred overnight. The reaction
was then extracted with 2!20 mL of H2O, the combined
aqueous layers were washed with 1!20 mL CHCl3,
concentrated on the rotary evaporator to 5 mL, and the
bright red viscous solution was acidified with 2 mL of 1 N
HCl. The resulting yellow precipitate was filtered and the
resulting solid (485 mg) was chromatographed on silica
(20 mm!16 cm), eluting with 89:10:1 CHCl3:MeOH:
AcOH. The desired product (43 mg, 8.5%) was isolated as
a bright yellow–orange solid; mp 78–80 8C. 1H NMR
(CDCl3): d 8.40–8.36 (m, 2H); 8.10 (dd, 1H, JZ8.1,
1.5 Hz); 7.74 (td, 1H, JZ7.8, 1.5 Hz); 7.43 (d, 1H, JZ
7.8 Hz); 7.31–7.23 (m, 2H); 6.69 (t, 2H, JZ0.9 Hz); 6.59 (s,
4H); 4.34 (s, 2H). 13C NMR (DMSO-d6): d 167.4, 156.7,
152.4, 148.8, 142.8, 136.8, 136.5, 129.5, 129.3, 122.5,
122.4, 122.0, 109.1, 102.5, 102.3, 48.0. HRMS(MCH):
4.2.15. 30,60-Pyrrolidinofluoran (9)—method B. 30,60-
Dibromofluoran (229 mg, 0.5 mmol) was combined with
palladium dibenzylideneacetone (11.5 mg, 0.0125 mmol;
0.025 mmol Pd), 0 sodium tert-butoxide (101 mg,
1.05 mmol), and 2 -dimethylamino-2-dicyclohexyl-phos-
phinobiphenyl (10.3 mg, 0.025 mmol) in a thick-walled
tube fitted with a rubber septum. The tube was thrice
evacuated and back-filled with N2, and 1.5 mL of dry
toluene was added, followed by 90 mL (77 mg, 1.08 mmol)
of pyrrolidine. The septum was replaced with a Teflon screw
cap and the reaction was stirred in an 80 8C oil bath for 15 h,
then removed from heat and allowed to cool. Hexanes were
added to the purple slurry, and a purple solid was isolated by
filtration (350 mg, wet) LCMS and 1H NMR analysis of the
solid supported a single product identical to those produced
by method A.